Total Payments
$8,813
2024 Payments
$1,758
Companies
35
Transactions
413
Medicare Patients
7,408
Medicare Billing
$587,845
Payment Breakdown by Category
Food & Beverage$8,569 (97.2%)
Education$243.94 (2.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,569 | 410 | 97.2% |
| Education | $243.94 | 3 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,627 | 57 | $0 (2024) |
| Janssen Biotech, Inc. | $718.04 | 30 | $0 (2024) |
| LEO Pharma Inc. | $616.19 | 36 | $0 (2023) |
| Lilly USA, LLC | $596.81 | 29 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $575.98 | 27 | $0 (2024) |
| GENZYME CORPORATION | $507.13 | 16 | $0 (2024) |
| Galderma Laboratories, L.P. | $427.86 | 17 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $386.77 | 21 | $0 (2024) |
| MAYNE PHARMA INC. | $361.09 | 36 | $0 (2020) |
| Amgen Inc. | $335.81 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,758 | 71 | ABBVIE INC. ($291.34) |
| 2023 | $997.92 | 32 | AbbVie Inc. ($367.93) |
| 2022 | $1,122 | 40 | LEO Pharma Inc. ($232.25) |
| 2021 | $732.03 | 42 | AbbVie Inc. ($108.24) |
| 2020 | $1,655 | 89 | Novartis Pharmaceuticals Corporation ($215.17) |
| 2019 | $1,790 | 96 | AbbVie, Inc. ($415.17) |
| 2018 | $596.63 | 38 | Lilly USA, LLC ($168.88) |
| 2017 | $161.67 | 5 | Galderma Laboratories, L.P. ($102.06) |
All Payment Transactions
413 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Inflammation & Immunology | ||||||
| 11/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $42.48 | General |
| Category: Immunology | ||||||
| 10/17/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $12.68 | General |
| 10/17/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $4.90 | General |
| 10/02/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $40.58 | General |
| Category: Immunology | ||||||
| 09/18/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Inflammation & Immunology | ||||||
| 09/10/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Dermatology | ||||||
| 09/09/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | — | Education | In-kind items and services | $64.95 | General |
| 09/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: IMMUNOLOGY | ||||||
| 09/04/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Immunology | ||||||
| 08/27/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $34.64 | General |
| Category: Dermatology | ||||||
| 08/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Immunology | ||||||
| 08/21/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: DERMATOLOGY | ||||||
| 08/20/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $27.46 | General |
| Category: Inflammation | ||||||
| 08/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: IMMUNOLOGY | ||||||
| 08/12/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $18.15 | General |
| Category: Dermatology | ||||||
| 08/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $27.26 | General |
| Category: IMMUNOLOGY | ||||||
| 07/31/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Immunology | ||||||
| 07/25/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Inflammation | ||||||
| 07/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/24/2024 | Organogenesis Inc. | — | Food and Beverage | In-kind items and services | $46.72 | General |
| 07/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $79.99 | General |
| Category: Immunology | ||||||
| 07/11/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: Dermatology | ||||||
| 07/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $44.65 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 2,772 | 5,614 | $670,749 | $214,958 |
| 2022 | 23 | 3,499 | 7,531 | $898,314 | $294,816 |
| 2021 | 11 | 1,137 | 1,924 | $203,903 | $78,071 |
Total Patients
7,408
Total Services
15,069
Medicare Billing
$587,845
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 633 | 860 | $154,139 | $48,514 | 31.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 341 | 416 | $82,862 | $25,942 | 31.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 256 | 298 | $66,197 | $22,301 | 33.7% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 35 | 68 | $53,191 | $20,851 | 39.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 453 | 576 | $76,279 | $19,310 | 25.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 153 | 179 | $45,489 | $14,033 | 30.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 383 | 2,607 | $33,570 | $12,374 | 36.9% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2023 | 35 | 52 | $28,120 | $9,750 | 34.7% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 32 | 35 | $21,068 | $7,546 | 35.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 110 | 110 | $24,688 | $7,365 | 29.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 94 | 147 | $14,554 | $5,596 | 38.5% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 38 | 44 | $15,556 | $5,253 | 33.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 35 | 38 | $12,677 | $4,204 | 33.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $6,990 | $2,351 | 33.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 57 | 60 | $6,712 | $2,343 | 34.9% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 23 | 24 | $11,652 | $2,284 | 19.6% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 12 | 13 | $4,869 | $1,835 | 37.7% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 15 | 16 | $3,957 | $1,319 | 33.3% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2023 | 19 | 19 | $3,433 | $767.30 | 22.4% |
| 69100 | Biopsy of ear | Office | 2023 | 16 | 16 | $3,060 | $600.54 | 19.6% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 11 | 15 | $1,686 | $418.69 | 24.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 733 | 1,091 | $198,237 | $64,974 | 32.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 328 | 417 | $93,708 | $33,775 | 36.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 395 | 491 | $99,759 | $31,123 | 31.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 537 | 725 | $97,288 | $24,696 | 25.4% |
About Dr. Ivette Sosa Seda, M.D
Dr. Ivette Sosa Seda, M.D is a Dermatology healthcare provider based in Jacksonville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/11/2008. The National Provider Identifier (NPI) number assigned to this provider is 1225287576.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ivette Sosa Seda, M.D has received a total of $8,813 in payments from pharmaceutical and medical device companies, with $1,758 received in 2024. These payments were reported across 413 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($8,569).
As a Medicare-enrolled provider, Sosa Seda has provided services to 7,408 Medicare beneficiaries, totaling 15,069 services with total Medicare billing of $587,845. Data is available for 3 years (2021–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Jacksonville, FL
- Active Since 09/11/2008
- Last Updated 05/01/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1225287576
Products in Payments
- TREMFYA (Drug) $775.89
- TALTZ (Drug) $596.81
- DUPIXENT (Biological) $571.30
- SKYRIZI (Biological) $513.43
- RINVOQ (Biological) $437.30
- DORYX (Drug) $361.09
- Humira (Biological) $357.62
- EPIDUO FORTE (Drug) $314.78
- Otezla (Drug) $314.66
- ADBRY (Biological) $313.32
- ENSTILAR (Drug) $302.87
- ILUMYA (Biological) $278.29
- EUCRISA (Drug) $220.33
- Sotyktu (Drug) $208.66
- Tremfya (Drug) $197.59
- OPZELURA (Drug) $145.38
- Seysara (Drug) $143.70
- COSENTYX (Biological) $129.14
- DUPIXENT (Drug) $125.47
- AMZEEQ (Drug) $124.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Jacksonville
Dr. Pearl Kwong, Md Phd, MD PHD
Dermatology — Payments: $2.8M
Dermatology $2.8M
Michael Bernhardt, Md, MD
Dermatology — Payments: $702,961
Dermatology $702,961
Kristen Stewart, M.d, M.D
Dermatology — Payments: $107,300
Dermatology $107,300
Jason Sluzevich, Md, MD
Dermatology — Payments: $61,523
Dermatology $61,523
Dr. Douglas Robins, Md, MD
Dermatology — Payments: $24,873
Dermatology $24,873
Jean Mcclintock, Md, MD
Dermatology — Payments: $14,036
Dermatology $14,036